^™middle.

Gathering signals...

Iperion (NZX:IPR) — Material Events

NZX:IPR · 2 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

1

Iperion narrows loss but cash support remains central to Pathoglaze planMedium

Iperion reports lower loss but relies on related-party funding as Pathoglaze manufacturing moves to Singapore

30 Sept 2026 ·Annual Meeting Presentation ·78

Notable Score 50–74

1

Iperion narrows loss as Pathoglaze licence targets waived and loan facility securedMedium

Iperion Limited reports reduced net loss and ongoing development of antimicrobial product with waived license targets and secured loan facility

1 July 2026 ·Annual Report ·50

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.